In conclusion, one-year anti-TNF treatment itself, as well as disease activity, CATHK, RANKL and possibly baseline VITD are the most important denominators of volumetric BMD changes over time in RA and AS. This evidence concerns the gene TNF and rheumatoid arthritis.